3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Gastrointestinal
1
Dermatologic
1
Conditions
Multiple Myeloma
6
Venous Thromboembolism
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Dexamethasone
109
pomalidomide
52
Cyclophosphamide
52
Bortezomib
41
fludarabine phosphate
33
Lenalidomide
33
Peripheral Blood Stem Cell Transplantation
28
carfilzomib
26
Mycophenolic Acid
25
Calcium Dobesilate
24
daratumumab
23
Cyclosporine
22
Busulfan
21
Antilymphocyte Serum
20
Tacrolimus
19
Whole-Body Irradiation
18
Melphalan
17
Radiotherapy
15
Filgrastim
15
Methotrexate
14
fludarabine
12
Methylprednisolone
12
elotuzumab
11
Cord Blood Stem Cell Transplantation
11
selinexor
10
ixazomib
9
Etoposide
8
Thalidomide
7
Prednisone
7
Panobinostat
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Observation
×
Plasma cell
×
Clear all
NCT02572492
2018-08-17
CARFI
Aalborg University Hospital
Phase 2
Unknown
200 enrolled